The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3

Stopped early · Not applicable · Has a placebo group

Conditions studied: Cocaine Abuse, Cocaine-Related Disorders

In brief

Gamma-aminobutyric acid (GABA) is a type of neurotransmitter, which is a chemical that transmits information within and from the brain to all parts of the body. By lowering the level of another neurotransmitter called dopamine, GABA may have the ability to diminish cocaine cravings in addicts. The purpose of this study is to gather information on the interaction between cocaine and selected GABA enhancing medications in individuals addicted to cocaine. This may lead to future clinical studies using GABA medications to treat cocaine addiction.

Key facts

Study ID
NCT00142883
Run by
Yale University
People needed
72
Starts
2004-09-01
Expected to finish
2006-09-01
Last updated by the study team
2015-07-08

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.